Hospital
Parkridge Medical Center, INC.
Parkridge Medical Center, INC. was paid $12.81M by Medicaid between Jan 2018 and Dec 2024, across 41 billing codes. Its largest line is 99283, emergency room visit (moderate) — 59% of everything it billed.
33Billing provider infoPARKRIDGE MEDICAL CENTER, INC.
CHATTANOOGA, TN 37412
CHATTANOOGA, TN 37412
33aNPI1659321198assigned 05/12/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$12.81M
24GClaims107,725
24DCodes billed41
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Tennessee
Rank by total paid#24 of 71
Median peer was paid$6.96M
This provider vs. median1.8×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 14,356 | $2.10M | |
| 2019 | 17,245 | $2.26M | |
| 2020 | 11,376 | $1.43M | |
| 2021 | 13,307 | $1.64M | |
| 2022 | 16,455 | $1.90M | |
| 2023 | 22,270 | $2.07M | |
| 2024incomplete | 12,716 | $1.40M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 59% | 26,620 | 25,317 | $7.59M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 37% | 13,250 | 12,315 | $4.68M |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 2.2% | 5,861 | 5,452 | $282K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 604 | 589 | $98K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 3,094 | 2,966 | $59K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 784 | 759 | $39K |
| 59025 | Fetal non-stress test | <1% | 566 | 393 | $15K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 585 | 540 | $13K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 5,943 | 5,622 | $11K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 374 | 365 | $11K |
| 80053 | Comprehensive metabolic panel | <1% | 9,133 | 8,452 | $4K |
| 85027 | <1% | 13,301 | 12,319 | $4K |
29 more codes
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 5,715 | $2K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 341 | $2K |
| 84703 | <1% | 6,301 | $2K | |
| 81001 | <1% | 7,026 | $1K | |
| 83690 | <1% | 1,056 | $463.17 | |
| 86160 | <1% | 336 | $240.37 | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 687 | $229.97 |
| 71045 | Radiologic examination, chest; single view | <1% | 1,183 | $197.45 |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 165 | $190.97 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 463 | $139.04 |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 576 | $99.93 |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 878 | $90.01 |
| 81003 | <1% | 1,464 | $60.83 | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 81 | $51.24 |
| 84484 | <1% | 144 | $43.45 | |
| 82784 | <1% | 133 | $36.56 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 480 | $17.71 |
| 71046 | Radiologic examination, chest; 2 views | <1% | 74 | $14.38 |
| 85018 | <1% | 28 | $13.36 | |
| 85014 | <1% | 28 | $13.36 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 33 | $1.30 |
| 83735 | 0% | 12 | $0.00 | |
| 87070 | 0% | 135 | $0.00 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 0% | 28 | $0.00 |
| J7120 | Ringers lactate infusion, up to 1000 cc | 0% | 124 | $0.00 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 0% | 44 | $0.00 |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 0% | 34 | $0.00 |
| 86756 | 0% | 28 | $0.00 | |
| 84702 | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialCRABTREE, JACKSON (CFO)